These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3726077)

  • 1. The placebo control in clinical trials (a view from the FDA).
    Leber P
    Psychopharmacol Bull; 1986; 22(1):30-2. PubMed ID: 3726077
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA uneasy about placebo revision.
    Hollon T
    Nat Med; 2001 Jan; 7(1):7. PubMed ID: 11135592
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of one-sided tests in drug trials: an FDA advisory committee member's perspective.
    Fisher LD
    J Biopharm Stat; 1991; 1(1):151-6. PubMed ID: 1844686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another meeting on the Helsinki Declaration.
    Bull Med Ethics; 2001 Mar; (166):13-4. PubMed ID: 11878333
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA principles on clinical investigations.
    Anello C
    Psychopharmacol Bull; 1972 Apr; 8(2):31-5. PubMed ID: 4550366
    [No Abstract]   [Full Text] [Related]  

  • 6. The rationale for placebo-controlled trials: methodology and policy considerations.
    Miller FG
    Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA signals it's open to drug trials that shift midcourse.
    Mathews AW
    Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16858817
    [No Abstract]   [Full Text] [Related]  

  • 8. The placebo: promise and compromise.
    Regan J; Hamer G; Wright A; Armour A; Fu J
    Tenn Med; 2005 Mar; 98(3):138-9. PubMed ID: 15974105
    [No Abstract]   [Full Text] [Related]  

  • 9. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study designs and outcomes in antidepressant clinical trials.
    Khan A; Schwartz K
    Essent Psychopharmacol; 2005; 6(4):221-6. PubMed ID: 16041918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should the FDA be the doctor of last resort?
    DeVita VT
    Nat Clin Pract Oncol; 2005 Sep; 2(9):423. PubMed ID: 16264991
    [No Abstract]   [Full Text] [Related]  

  • 13. Placebo response in generalized anxiety: its effect on the outcome of clinical trials.
    Schweizer E; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():30-8. PubMed ID: 9363046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 15. Research infrastructure and IRB/FDA requirements.
    Cohen J
    Med Health R I; 2000 Dec; 83(12):382-5. PubMed ID: 11190124
    [No Abstract]   [Full Text] [Related]  

  • 16. Overhauling clinical trials.
    Scott CT; Baker M
    Nat Biotechnol; 2007 Mar; 25(3):287-92. PubMed ID: 17344876
    [No Abstract]   [Full Text] [Related]  

  • 17. Placebo-controlled trials and the logic of clinical purpose.
    Freedman B
    IRB; 1990; 12(6):1-6. PubMed ID: 11651265
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical development of atypical antipsychotics: research design and evaluation. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():10-6. PubMed ID: 9766614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in the design of clinical trials for safety in HIV-infected children.
    Lindsey JC; Kline MW
    Pediatr AIDS HIV Infect; 1996 Apr; 7(2):69-82. PubMed ID: 11361484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.